HEADER TRANSFERASE 02-MAR-18 6FVG TITLE THE STRUCTURE OF CK2ALPHA WITH CCH507 BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 2-329; COMPND 5 SYNONYM: CK II ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHAT2 KEYWDS CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION KEYWDS 2 SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY KEYWDS 3 REDUCTION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.BREAR,R.PRUDENT,B.LAUDET,O.FILHOL,C.COCHET,C.SAUTEL,V.MOUCADEL, AUTHOR 2 B.BESTGEN,M.ENGEL,M.ETTAOUSSI,T.LOMBERGET,M.LE BORGNE,I.KUFAREVA, AUTHOR 3 R.ABAGYAN,M.HYVONEN REVDAT 3 17-JAN-24 6FVG 1 REMARK REVDAT 2 01-JUL-20 6FVG 1 JRNL REVDAT 1 19-JUN-19 6FVG 0 JRNL AUTH I.KUFAREVA,B.BESTGEN,P.BREAR,R.PRUDENT,B.LAUDET,V.MOUCADEL, JRNL AUTH 2 M.ETTAOUSSI,C.F.SAUTEL,I.KRIMM,M.ENGEL,O.FILHOL,M.L.BORGNE, JRNL AUTH 3 T.LOMBERGET,C.COCHET,R.ABAGYAN JRNL TITL DISCOVERY OF HOLOENZYME-DISRUPTING CHEMICALS AS JRNL TITL 2 SUBSTRATE-SELECTIVE CK2 INHIBITORS. JRNL REF SCI REP V. 9 15893 2019 JRNL REFN ESSN 2045-2322 JRNL PMID 31685885 JRNL DOI 10.1038/S41598-019-52141-5 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 42744 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2158 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.89 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3119 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2861 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2977 REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE : 0.2872 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.55 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2748 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.72680 REMARK 3 B22 (A**2) : 0.52420 REMARK 3 B33 (A**2) : 2.20260 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.82310 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.105 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.098 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.104 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.098 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2958 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4025 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1051 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 74 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 460 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2958 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 356 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3283 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.92 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.70 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.32 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FVG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009012. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92818 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.26 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43028 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 56.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.72700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5CU6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 112.5MM MES PH 6.5, 35% GLYCEROL REMARK 280 ETHOXYLATE, 180 MM AMMONIUM ACETATE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.96550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 108 140.13 -38.94 REMARK 500 THR A 119 -133.20 54.32 REMARK 500 ASP A 156 42.05 -147.47 REMARK 500 ASP A 175 79.39 49.95 REMARK 500 ASP A 175 79.31 50.05 REMARK 500 ALA A 193 167.00 62.71 REMARK 500 ALA A 193 167.12 62.71 REMARK 500 HIS A 234 71.15 -100.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E8K A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ATP A 402 DBREF 6FVG A 2 329 UNP P68400 CSK21_HUMAN 2 329 SEQADV 6FVG SER A 21 UNP P68400 ARG 21 ENGINEERED MUTATION SEQADV 6FVG ALA A 74 UNP P68400 LYS 74 ENGINEERED MUTATION SEQADV 6FVG ALA A 75 UNP P68400 LYS 75 ENGINEERED MUTATION SEQADV 6FVG ALA A 76 UNP P68400 LYS 76 ENGINEERED MUTATION SEQRES 1 A 328 SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP SEQRES 2 A 328 VAL ASN THR HIS ARG PRO SER GLU TYR TRP ASP TYR GLU SEQRES 3 A 328 SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN SEQRES 4 A 328 LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL SEQRES 5 A 328 PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL SEQRES 6 A 328 VAL LYS ILE LEU LYS PRO VAL ALA ALA ALA LYS ILE LYS SEQRES 7 A 328 ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO SEQRES 8 A 328 ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SEQRES 9 A 328 SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN SEQRES 10 A 328 THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR SEQRES 11 A 328 ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU SEQRES 12 A 328 ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL SEQRES 13 A 328 LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS SEQRES 14 A 328 LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS SEQRES 15 A 328 PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR SEQRES 16 A 328 PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR SEQRES 17 A 328 ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET LEU SEQRES 18 A 328 ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY SEQRES 19 A 328 HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL SEQRES 20 A 328 LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR SEQRES 21 A 328 ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY SEQRES 22 A 328 ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER SEQRES 23 A 328 GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE SEQRES 24 A 328 LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU SEQRES 25 A 328 THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR SEQRES 26 A 328 VAL VAL LYS HET E8K A 401 31 HET ATP A 402 31 HETNAM E8K [1-[2-(PHENYLSULFONYLAMINO)ETHYL]PIPERIDIN-4-YL]METHYL HETNAM 2 E8K 1~{H}-INDOLE-3-CARBOXYLATE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 2 E8K C23 H27 N3 O4 S FORMUL 3 ATP C10 H16 N5 O13 P3 FORMUL 4 HOH *191(H2 O) HELIX 1 AA1 ASP A 14 ARG A 19 1 6 HELIX 2 AA2 PRO A 20 ASP A 25 1 6 HELIX 3 AA3 TYR A 26 HIS A 29 5 4 HELIX 4 AA4 ASN A 35 ASP A 37 5 3 HELIX 5 AA5 PRO A 72 ALA A 76 5 5 HELIX 6 AA6 LYS A 77 ARG A 89 1 13 HELIX 7 AA7 ASP A 120 TYR A 125 1 6 HELIX 8 AA8 THR A 129 MET A 150 1 22 HELIX 9 AA9 LYS A 158 HIS A 160 5 3 HELIX 10 AB1 SER A 194 LYS A 198 5 5 HELIX 11 AB2 GLY A 199 VAL A 204 1 6 HELIX 12 AB3 TYR A 211 ARG A 228 1 18 HELIX 13 AB4 ASP A 237 GLY A 250 1 14 HELIX 14 AB5 GLY A 250 TYR A 261 1 12 HELIX 15 AB6 ASP A 266 ASN A 270 5 5 HELIX 16 AB7 ARG A 280 VAL A 285 5 6 HELIX 17 AB8 ASN A 289 VAL A 293 5 5 HELIX 18 AB9 SER A 294 LEU A 305 1 12 HELIX 19 AC1 THR A 314 GLU A 320 1 7 HELIX 20 AC2 HIS A 321 TYR A 325 5 5 SHEET 1 AA1 5 TYR A 39 ARG A 47 0 SHEET 2 AA1 5 SER A 51 ASN A 58 -1 O VAL A 53 N LEU A 45 SHEET 3 AA1 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 AA1 5 PRO A 109 GLU A 114 -1 O LEU A 111 N LYS A 68 SHEET 5 AA1 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -3.25 SITE 1 AC1 15 GLN A 36 TYR A 39 LEU A 41 GLU A 52 SITE 2 AC1 15 ILE A 69 LEU A 70 LYS A 71 PRO A 72 SITE 3 AC1 15 ASP A 103 PRO A 104 VAL A 105 SER A 106 SITE 4 AC1 15 THR A 108 ARG A 280 HOH A 541 SITE 1 AC2 13 LEU A 45 GLY A 46 ARG A 47 VAL A 53 SITE 2 AC2 13 VAL A 66 ILE A 95 GLU A 114 VAL A 116 SITE 3 AC2 13 ASP A 120 LYS A 158 HIS A 160 MET A 163 SITE 4 AC2 13 ILE A 174 CRYST1 60.183 45.931 63.706 90.00 111.22 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016616 0.000000 0.006452 0.00000 SCALE2 0.000000 0.021772 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016839 0.00000